Increased cerebrospinal fluid glutamine levels in depressed patients

Biological Psychiatry

Volumn 47, Issue 7, 2000, Pages 586-593

  Levine, Joseph ^a,b   Panchalingam, Kanagasabai ^a   Rapoport, Avraham ^c   Gershon, Samuel ^a   McClure, Richard J ^a   Pettegrew, Jay W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

hydroxybutyrate; 1H MRS; Creatine; Glutamine; Major depression

Indexed keywords

3 HYDROXYBUTYRIC ACID; CREATINE; CREATININE; GLUTAMINE; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AFFECTIVE NEUROSIS; AGE; AGED; ARTICLE; BIPOLAR DEPRESSION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; MALE; METABOLITE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CREATINE; DEPRESSIVE DISORDER; FEMALE; GLUTAMINE; HUMANS; HYDROXYBUTYRATES; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0034176029     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00284-X     Document Type: Article

References (44)

1. Agren H., Niklasson F. Creatinine and creatine in CSF Indices of brain energy metabolism in depression . J Neural Transm. 74:1988;55-59.
2. Altamura C., Maes M., Dai J., Meltzer H.Y. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur Neuropsychopharmacol. 5:(suppl):1995;71-75.
3. Altamura C.A., Mauri M.C., Ferrara A., Moro A.R., D'Andrea G., Zamberlan F. Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry. 150:1993;1731-1733.
4. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Psychiatric Disorders, 3rd rev ed. Washington, DC: American Psychiatric Press.
5. Barkai A., Dunner D., Gross H., Mayo P., Fieve R. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry. 13:1978;65-72.
6. Chauhan S., Jailkhani R., Subrahmanyam D. Effect of undernutrition on lipid metabolism of brain. In vivo incorporation of labelled acetate and palmitate into lipids. Nutr Metab. 24:1980;43-49.
7. Dubovsky S.L., Murphy J., Thomas M., Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 149:1992;118-120.
8. Gerner R.H., Hare T.A. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry. 138:1981;1098-1101.
9. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
10. Hauang N.-U., Layer R.T., Skolnick P. Is an adaptation of NMDA receptors an obligatory step in antidepressant action? Skolnick P. Antidepressants New Pharmacological Strategies . 1997;125-144 Humana, Totowa, NJ.
11. Heresco-Levy U., Javitt D.C. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol. 8:1998;141-152.
12. Hiraoka A., Miura I., Tominaga I., Hattori M. Capillary-isotachophoretic determination of glutamine in cerebrospinal fluid of various neurological disorders. Clin Biochem. 22:1989;293-296.
13. Kato T., Shioiri T., Murashita J., Hamakawa H., Inubushi T., Takahashi S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res. 61:1995;151-160.
14. Kim J.S., Schmid-Burgk W., Claus D., Kornhuber H.H. Increased serum glutamate in depressed patients. Arch Psychiatrie Nervenkrankheiten. 232:1982;299-304.
15. Klunk W.E., Xu C.J., Panchalingam K., McClure R.J., Pettegrew J.W. Analysis of magnetic resonance spectra by mole percent Comparison to absolute units . Neurobiol Aging. 15:1994;133-140.
16. Korpi E.R., Kaufmann C.A., Marnela K.M., Weinberger D.R. Cerebrospinal fluid amino acid concentrations in chronic schizophrenia. Psychiatry Res. 20:1987;337-345.
17. Langhans W., Pantel K., Scharrer E. Ketone kinetics and D-(-)-3-hydroxybutyrate-induced inhibition of feeding in rats. Physiol Behav. 34:1985;579-582.
18. Levine J., Barak Y., Gonzalves M., Szor H., Elizur A., Kofman O., et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry. 152:1995;792-794.
19. Levine J., Kurtzman L., Rapoport A., Zimmerman J., Bersudsky Y., Shapiro J., et al. CSF inositol does not predict antidepressant response to inositol. J Neural Transm. 103:1997;1457-1463.
20. Levine J., Stein D., Rapoport A., Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 39:1999;63-70.
21. Maes M. Cytokines and major depression. Biol Psychiatry. 43:1997;313-314.
22. Maes M., Smith R., Christophe A., Vandoolaeghe E., Van Gastel A., Neels H., et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts Relationship with immune-inflammatory markers . Acta Psychiatr Scand. 95:1997;212-221.
23. Maj J., Rogoz Z., Skuza G., Sowinska H. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol. 2:1992;37-41.
24. Mathis P, Schmitt L, Benatia M, Granier F, Ghisolfi J, Moron P (1988): (Plasma amino acid disturbances and depression.) Encephale 14:77-82.
25. Mellerup E.T., Rafaelsen O.J. Depression and cerebrospinal fluid citrate. Acta Psychiatr Scand. 63:1981;57-60.
26. Miyake T., Kitamura T. Glutamine synthetase immunoreactivity in two types of mouse brain glial cells. Brain Res. 586:1992;53-60.
27. Morgan R.E., Palinkas L.A., Barrett-Connor E.L., Wingard D.L. Plasma cholesterol and depressive symptoms in older men. Lancet. 341:1993;75-79.
28. Niklasson F., Agren H. Brain energy metabolism and blood-brain barrier permeability in depressive patients analyses of creatine, creatinine, urate, and albumin in CSF and blood . Biol Psychiatry. 19:1984;1183-1206.
29. Nowak G., Layer R.T., Skolnick P., Paul I.A. Adaptation of the N-methyl-D-aspartate receptor following chronic antidepressants. (abstract). J Neurochem. 61:1993;S51.
30. Nowak G., Ordway G.A., Paul I.A. Alteration in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 675:1995;157-164.
31. Nowak G., Trullas R., Layer R.T., Skolnick P., Paul I.A. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther. 265:1993;1380-1386.
32. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
33. Paslawski T.M., Sloley B.D., Baker G.B. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. Prog Brain Res. 106:1995;181-186.
34. Paul I.A. NMDA receptors and affective disorders. Skolnick P. Antidepressants New Pharmacological Strategies . 1997;145-158 Humana, Totowa, NJ.
35. Petroff O.A., Yu R.K., Ogino T. High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J Neurochem. 47:1986;1270-1276.
36. Plaitakis A., Shashidharan P. A myotrophic lateral sclerosis, glutamate, and oxidative stress. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;1531-1543 Raven, New York.
37. Sharma R.P., Bissette G., Janicak P.G., Davis J.M., Nemeroff C.B. Elevation of CSF somatostatin concentrations in mania. Am J Psychiatry. 152:1995;1807-1809.
38. Sheline Y., Bardgett M.E., Csernansky J.G. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 17:1997;11-14.
39. Szweda L.I., Atkinson D.E. Response of rat liver glutaminase to magnesium ion. Biochim Biophys Acta. 1041:1990;201-206.
40. 2+ interactions. Neurochem Res. 12:1987;1041-1047.
41. Tholey G., Ledig M., Mandel P., Sargentini L., Frivold A.H., Leroy M., et al. Concentrations of physiologically important metal ions in glial cells cultured from chick cerebral cortex. Neurochem Res. 13:1988;45-50.
42. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol. 185:1990;1-10.
43. Wolever T.M., Fernandes J., Rao A.V. Serum acetate:propionate ratio is related to serum cholesterol in men but not women. J Nutr. 126:1996;2790-2797.
44. Yesavage J.A., Holman C.A., Berger P.A. Cerebrospinal fluid lactate levels and aging findings in normals and patients with major depressive disorders . Gerontology. 28:1982;377-380.